Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $729.85 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Relypsa, Inc. | $639.87 | 7 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $89.98 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $89.98 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($89.98) |
| 2019 | $187.92 | 2 | Relypsa, Inc. ($187.92) |
| 2018 | $273.75 | 3 | Relypsa, Inc. ($273.75) |
| 2017 | $178.20 | 2 | Relypsa, Inc. ($178.20) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/29/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $89.98 | General |
| Category: Cardio-renal | ||||||
| 09/05/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $96.81 | General |
| Category: Hyperkalemia | ||||||
| 05/24/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $91.11 | General |
| Category: Hyperkalemia | ||||||
| 09/08/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $68.04 | General |
| Category: Hyperkalemia | ||||||
| 09/05/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $124.49 | General |
| Category: Hyperkalemia | ||||||
| 08/28/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $81.22 | General |
| Category: Hyperkalemia | ||||||
| 11/03/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $69.15 | General |
| Category: Hyperkalemia | ||||||
| 05/31/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $109.05 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 342 | 546 | $164,627 | $42,098 |
| 2022 | 7 | 312 | 526 | $152,353 | $40,232 |
| 2021 | 8 | 283 | 486 | $136,090 | $37,331 |
| 2020 | 7 | 366 | 608 | $147,988 | $42,114 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 108 | 216 | $63,375 | $20,339 | 32.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 63 | 92 | $18,676 | $5,723 | 30.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 36 | $20,412 | $4,964 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 100 | $32,560 | $4,637 | 14.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 27 | 45 | $10,125 | $2,553 | 25.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $7,353 | $1,917 | 26.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $6,412 | $1,073 | 16.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 24 | $5,714 | $890.63 | 15.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 109 | 262 | $75,860 | $21,205 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 89 | $26,653 | $6,111 | 22.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 60 | 89 | $17,899 | $4,968 | 27.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $9,575 | $2,694 | 28.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 18 | $6,906 | $1,862 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 17 | $5,049 | $1,273 | 25.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 19 | 22 | $4,950 | $1,166 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $5,461 | $952.51 | 17.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 88 | 196 | $55,704 | $16,192 | 29.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 48 | 92 | $26,325 | $7,104 | 27.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 48 | 67 | $13,180 | $3,797 | 28.8% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 34 | 66 | $14,850 | $3,703 | 24.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 15 | $8,255 | $2,403 | 29.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 18 | $7,426 | $1,958 | 26.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $7,433 | $1,708 | 23.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 15 | $2,917 | $467.56 | 16.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 99 | 193 | $53,529 | $15,938 | 29.8% |
About Dr. Uta Erdbruegger, MD
Dr. Uta Erdbruegger, MD is a Nephrology healthcare provider based in Charlottesville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2009. The National Provider Identifier (NPI) number assigned to this provider is 1659519932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Uta Erdbruegger, MD has received a total of $729.85 in payments from pharmaceutical and medical device companies, with $89.98 received in 2022. These payments were reported across 8 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($729.85).
As a Medicare-enrolled provider, Erdbruegger has provided services to 1,303 Medicare beneficiaries, totaling 2,166 services with total Medicare billing of $161,775. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Charlottesville, VA
- Active Since 01/26/2009
- Last Updated 07/31/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1659519932
Products in Payments
- Veltassa (Drug) $639.87
- Kerendia (Drug) $89.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Charlottesville
Mitchell Rosner
Nephrology — Payments: $156,014
Rasheed Balogun, M.d, M.D
Nephrology — Payments: $11,685
Mark Okusa, M.d, M.D
Nephrology — Payments: $9,688
John Barcia, Md, MD
Nephrology — Payments: $2,166
Ross Isaacs, M.d, M.D
Nephrology — Payments: $1,077
Amanda Renaghan, M.d, M.D
Nephrology — Payments: $312.27